Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study
Angelo Ruggiero, Gabriella Fabbrocicni, Sara Cacciapuoti, Luca Potestio, Lucia Gallo, Matteo Megna Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyCorrespondence: Angelo Ruggiero, Section of Dermatology, Department of Clinical Medic...
| Main Authors: | , , , , , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Dove Medical Press
2023-02-01
|
| 丛编: | Clinical, Cosmetic and Investigational Dermatology |
| 主题: | |
| 在线阅读: | https://www.dovepress.com/tildrakizumab-for-the-treatment-of-moderate-to-severe-psoriasis-result-peer-reviewed-fulltext-article-CCID |